Estrella Immunopharma Warrant
ESLAW
12 hedge funds and large institutions have $245K invested in Estrella Immunopharma Warrant in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
30.04% more ownership
Funds ownership: 2.13% → 32.18% (+30%)
18% more capital invested
Capital invested by funds: $208K → $245K (+$36.8K)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$598 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
-$3.46K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $218K | – | – | – |
|
|
ASM
2
ATW SPAC Management
New York
| $9.48K | – | – | – |
|
3
D.E. Shaw & Co
New York
| $4.55K | – | – | – |
|
|
SIA
4
SkyView Investment Advisors
Shrewsbury,
New Jersey
| $3K | – | – | – |
|
|
YCM
5
Yakira Capital Management
Westport,
Connecticut
| $2.41K | – | – | – |
|
|
WA
6
Whitebox Advisors
Minneapolis,
Minnesota
| $2.19K | – | – | – |
|
7
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $1.86K | – | – | – |
|
|
CS
8
Clear Street
New York
| $1.76K | – | – | – |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $728 | +$598 | +13,997 | New |
|
|
LCM
10
Landscape Capital Management
Englewood,
New Jersey
| $709 | – | – | – |
|
|
WAM
11
Wolverine Asset Management
Chicago,
Illinois
| $113 | – | – | – |
|
|
12
UBS Group
Zurich,
Switzerland
| $67 | -$2 | -47 | -4% |
|
|
13
Walleye Trading
New York
| – | -$3.46K | -72,834 | Closed |
|
ESLAW Hedge Fund Activity: Q3 2025 in Review
12 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma Warrant (ESLAW) for Q3 2025, worth a combined $245K — up 18% from $208K a quarter earlier.
Fund positioning in ESLAW was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $598. The largest seller was Walleye Trading, exiting entirely with an estimated $3.46K sold.
- 12 institutional investors held Estrella Immunopharma Warrant (ESLAW) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $245K of Estrella Immunopharma Warrant stock for Q3 2025, up 18% quarter-over-quarter.
- 1 fund opened new Estrella Immunopharma Warrant positions in Q3 2025 and 1 closed out, a net change of 0 holders.
- The largest Estrella Immunopharma Warrant buyer in Q3 2025 was Susquehanna International Group, an estimated $598 added.
- The largest Estrella Immunopharma Warrant seller in Q3 2025 was Walleye Trading, an estimated $3.46K sold.
Based on aggregated 13F filings for Q3 2025.